A1 Refereed original research article in a scientific journal

11C-PiB PET assessment of change in fibrillar amyloid-beta load in patients with Alzheimer's disease treated with bapineuzumab: a phase 2, double-blind, placebo-controlled, ascending-dose study

Authors: Rinne JO, Brooks DJ, Rossor MN, Fox NC, Bullock R, Klunk WE, Mathis CA, Blennow K, Barakos J, Okello AA, Rodriguez Martinez de Liano S, Liu E, Koller M, Gregg, Schenk D, Black R, Grundman M

Publication year: 2010

Journal: Lancet Neurology

Number in series: 4

Volume: 9

Issue: 4

First page : 363

Last page: 372

Number of pages: 10

ISSN: 1474-4422

DOI: https://doi.org/10.1016/S1474-4422(10)70043-0